GLSK11008
| Product Description: |
|
Beconase Hayfever contains a corticosteroid called beclomethasone dipropionate. This has an anti-inflammatory action. Corticosteroids must be used regularly, every day, for maximum effect. Beconase Hayfever works by reducing swelling and irritation in the nose and so helps to relieve uncomfortable symptoms.
|
| HealthWarning: |
Beconase Hayfever does not cause drowsiness and does not affect your ability to drive or use machinery.
• You can still drink alcohol while you are using Beconase Hayfever.
• You may sneeze a little after using this spray but this soon stops. Very occasionally you may notice an unpleasant taste or smell. Occasionally people have nose bleeds. Some people may feel some irritation in their nose or throat. This usually goes away. Tell your doctor if your nose or throat becomes painful.
• If you have any problems with your eyes such as pain or blurred vision (glaucoma), or problems with your nose such as pain and / or persistent bleeding, tell your doctor as soon as possible.
• Some people can be allergic to medicines. If you develop a rash or swelling, stop taking this medicine, and tell your doctor immediately.
• Exceeding the dose level or recommended duration of treatment is not recommended as this may affect the normal production of corticosteroids in the body.
• If you feel your medicine has upset you in any way tell your doctor or pharmacist and follow their advice.
|
| Direction / Advice: |
Beconase Hayfever can be used any time in the year to prevent and treat the common symptoms of allergic rhinitis, including hayfever, such as sneezing and a runny, itchy or blocked-up nose. Allergic rhinitis can be brought on by different 'triggers', such as pollen, cats, dogs, horses, house dust etc. When your nose is cleared the pressure and pain around the nose and eyes is also reduced. Beconase Hayfever can be used by adults aged 18 or over.
Before you use Beconase Hayfever:
• Are you pregnant or planning to become pregnant?
• Are you breast-feeding a baby?
• Are you allergic to any of the ingredients?
• Do you have an infection in your nose?
• Have you recently been treated with a steroid injection, or taken steroid tablets for a long time?
If the answer to any of these questions is YES, talk to your doctor or pharmacist before using Beconase Hayfever.
Using your nasal spray
• Follow the instructions shown later in the leaflet. If you have any problems ask your pharmacist.
• Use only in your nose. Make sure you don't get the spray in your eyes.
Dose
Adults aged 18 or over: Two sprays into each nostril every morning and evening. Beconase Hayfever is not recommended for children or adolescents under 18 years of age. Shake before use. Beconase Hayfever quickly starts to reduce inflammation and swelling in your nose, although it may take 2 or 3 days to build up to its maximum protective effect. Therefore, to prevent the onset of symptoms start to use Beconase Hayfever two or three days before exposure to one of your usual 'triggers'. Once your symptoms have improved, you may be able to reduce the dose to one spray into each nostril every morning and evening. If your symptoms get worse again, return to a dose of two sprays into each nostril every morning and evening. Try to use the lowest dose that controls your symptoms. Do not use more than 8 sprays (400 micrograms) in a day. If your symptoms have not improved after 14 days consult your doctor. Do not use this product continuously for more than 3 months without consulting your doctor. If you miss a dose just take the next dose when it is due. Tell your doctor if you accidentally use more than you should.
|
| Ingredients: |
|
Beconase Hayfever contains 50 micrograms beclomethasone dipropionate as the active ingredient in each spray. It also contains microcrystalline cellulose, sodium carboxymethylcellulose, dextrose, polysorbate 80, purified water and the preservatives benzalkonium chloride and phenylethylalcohol. These other ingredients are needed to make a stable suspension which will not go off.
|
| © CopyRight: |
|
Copyright the GlaxoSmithKline group of companies 2003
|
|
